160 related articles for article (PubMed ID: 31558067)
41. An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial.
Lickliter JD; Taylor K; Szer J; Grigg A; Arthur C; Hughes TP; Durrant S; Filshie R; Irving I; Seldon M; Ellacott J; Boyd AW; D'Rozario J; Rooney K; Lynch K; Bradstock K;
Leuk Lymphoma; 2015 Mar; 56(3):630-8. PubMed ID: 24844361
[TBL] [Abstract][Full Text] [Related]
42. Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review.
Wang Z; Wan L; Lin D; Li CW; Tian Z; Mi YC
Acta Haematol; 2022; 145(5):560-565. PubMed ID: 35340014
[TBL] [Abstract][Full Text] [Related]
43. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.
Shin SY; Cho JH; Kim HJ; Jang JH; Lee ST; Kim SH
Ann Lab Med; 2015 Jan; 35(1):159-61. PubMed ID: 25553301
[No Abstract] [Full Text] [Related]
44. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Piccaluga PP; Paolini S; Martinelli G
Cancer; 2007 Sep; 110(6):1178-86. PubMed ID: 17701954
[TBL] [Abstract][Full Text] [Related]
45. Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia.
Sanchez-Gonzalez B; Pascual-Ramirez JC; Fernandez-Abellan P; Belinchon-Romero I; Rivas C; Vegara-Aguilera G
Blood; 2003 Mar; 101(6):2446. PubMed ID: 12609964
[No Abstract] [Full Text] [Related]
46. Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sciumè M; Fracchiolla NS; Cortelezzi A
Leuk Lymphoma; 2018 Oct; 59(10):2516-2517. PubMed ID: 29384412
[No Abstract] [Full Text] [Related]
47. JSH practical guidelines for hematological malignancies, 2018: I. leukemia-3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
Hatta Y; Hayakawa F; Yamazaki E
Int J Hematol; 2020 Oct; 112(4):439-458. PubMed ID: 32812190
[No Abstract] [Full Text] [Related]
48. [Prolonged molecular response induced by imatinib in Philadelphia positive acute lymphoblastic leukemia A case report and brief review].
Raissi A; Bouaouad M; Drideb NA; Jennane S; Mahtat el M; Doghmi K; Mikdame M
Ann Biol Clin (Paris); 2015; 73(2):195-8. PubMed ID: 25847743
[TBL] [Abstract][Full Text] [Related]
49. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
Schultz KR; Bowman WP; Aledo A; Slayton WB; Sather H; Devidas M; Wang C; Davies SM; Gaynon PS; Trigg M; Rutledge R; Burden L; Jorstad D; Carroll A; Heerema NA; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B
J Clin Oncol; 2009 Nov; 27(31):5175-81. PubMed ID: 19805687
[TBL] [Abstract][Full Text] [Related]
50. Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia.
Thomas D
Lancet Oncol; 2012 Sep; 13(9):860-2. PubMed ID: 22935232
[No Abstract] [Full Text] [Related]
51. A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5).
Ghazzawi M; Mehra V; Knut M; Brown L; Tapper W; Chase A; de Lavallade H; Cross NCP
Acta Haematol; 2017; 138(4):198-200. PubMed ID: 29169164
[No Abstract] [Full Text] [Related]
52. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
Jeha S; Coustan-Smith E; Pei D; Sandlund JT; Rubnitz JE; Howard SC; Inaba H; Bhojwani D; Metzger ML; Cheng C; Choi JK; Jacobsen J; Shurtleff SA; Raimondi S; Ribeiro RC; Pui CH; Campana D
Cancer; 2014 May; 120(10):1514-9. PubMed ID: 24501014
[TBL] [Abstract][Full Text] [Related]
53. Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ishii Y; Shoji N; Kimura Y; Ohyashiki K
Intern Med; 2006; 45(5):339-40. PubMed ID: 16596010
[No Abstract] [Full Text] [Related]
54. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
55. Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.
Heilmann AM; Schrock AB; He J; Nahas M; Curran K; Shukla N; Cramer S; Draper L; Verma A; Erlich R; Ross J; Stephens P; Miller VA; Ali SM; Verglio JA; Tallman MS; Mughal TI
Leukemia; 2017 Sep; 31(9):1989-1992. PubMed ID: 28552906
[No Abstract] [Full Text] [Related]
56. A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
Chiaretti S; Vitale A; Vignetti M; Piciocchi A; Fazi P; Elia L; Falini B; Ronco F; Ferrara F; De Fabritiis P; Luppi M; La Nasa G; Tedeschi A; Califano C; Fanin R; Dore F; Mandelli F; Meloni G; Foà R
Haematologica; 2016 Dec; 101(12):1544-1552. PubMed ID: 27515250
[TBL] [Abstract][Full Text] [Related]
57. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041
[TBL] [Abstract][Full Text] [Related]
58. Huaier extract enhances the treatment efficacy of imatinib in Ik6
Qu P; Han J; Qiu Y; Yu H; Hao J; Jin R; Zhou F
Biomed Pharmacother; 2019 Sep; 117():109071. PubMed ID: 31202171
[TBL] [Abstract][Full Text] [Related]
59. In vitro drug resistance to imatinib and mutation of ABL gene in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.
Kawaguchi H; Taketani T; Hongo T; Park MJ; Koh K; Ida K; Kobayashi M; Takita J; Taki T; Yoshino H; Bessho F; Hayashi Y
Leuk Lymphoma; 2005 Feb; 46(2):273-6. PubMed ID: 15621812
[TBL] [Abstract][Full Text] [Related]
60. An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Li XY; Qian JJ; Yang M; Zhang Y; Wang SS; Meng HT; Yu WJ; Tong HY; Ye XJ; Jin J; Zhu HH
Br J Haematol; 2020 Jun; 189(6):e231-e234. PubMed ID: 32314800
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]